Study title: A phase IV Multi-Center, Open-label Safety Study in pediatric Patients with atopic dermatitis, Treated with Diprolen AF Cream 0,05 % Twice daily, or diprosone ointment
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Skin and Connective Tissue Diseases [C17] | |||||
Brands: Please see report | |||||
MAH holders: Please see report | |||||
Assessment: | |||||
Active substance: BETAMETHASONE | |||||
ATC code: D07A C01 | |||||
Document link: | |||||
Document date: | |||||
Study number: P01260 | |||||
EudraCT number: | |||||
Scope of study: CLINICAL | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | - | - |